Schulz-Knappe P, Schrader M, Ständker L, Richter R, Hess R, Jürgens M, Forssmann W G
Niedersächsisches Institut für Peptid-Forschung GmbH, Hannover, Germany.
J Chromatogr A. 1997 Jul 25;776(1):125-32. doi: 10.1016/s0021-9673(97)00152-0.
Human hemofiltrate (HF) is a source for the purification of circulating regulatory peptides. HF is obtained in large quantities during treatment of patients suffering from chronic renal failure. We have developed a large-scale method for separating peptides from amounts up to 10,000 1 HF into 300 fractions in a standardized two-step procedure, employing cation-exchange separation, followed by reversed-phase chromatography. These fractions represent a peptide bank containing bioactive, desalted and lyophilized peptides of blood. Screening for and isolation of regulatory human peptides is simplified by using this peptide bank.